32
Participants
Start Date
October 31, 2005
Primary Completion Date
June 6, 2013
Study Completion Date
November 10, 2016
Bevacizumab
Bevacizumab 15 mg/kg IV infusion given on day 1 every 21 days = (1 cycle).
Fox Chase Cancer Center CCOP Research Base, Philadelphia
Mayo Clinic Cancer Center, Rochester
Rebecca and John Moores UCSD Cancer Center, La Jolla
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
M. D. Anderson Cancer Center at University of Texas, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Northwestern University
OTHER